What Is the Dividend Payout for AbbVie Stock?

Group 1 - AbbVie is not only a quality healthcare holding but also a compelling income investment due to its strong dividend stock profile [1] - Humira, AbbVie's top-selling product, accounted for 25% of the company's total revenue of $54.3 billion last year, but its revenue has declined by 35% year over year in Q1 following the loss of patent protection [2][3] - Despite concerns about the sustainability of AbbVie's dividend, the company has potential growth from other drugs like Skyrizi and Rinvoq, which could significantly increase sales in the coming years [3] Group 2 - AbbVie currently pays quarterly dividends at an annualized rate of $6.20 per share, with earnings per share projected between $12 to $13, indicating a strong capacity for continued dividend increases [4] - The current dividend yield for AbbVie stands at 3.9%, with fluctuations between 3.3% and 4.4% over the past year, aligning with its average yield over the last decade [4]